Remote Health
Recent news:
BioE postdoc Trinh Lam’s animated video explains how Herr Lab’s BlotSeq single-cell tool uses sequencing data to guide protein selection without the need to predefine targets, making the process more flexible.
Trinh Lam, a postdoc in Amy Herr’s lab, has won the Biomicrofluidics Best Paper Award from AIP Publishing at the 28th International Conference on Miniaturized Systems for Chemistry and Life Sciences – Micro-Total Analysis Systems (µTAS 2024).
Professor Aaron Streets was featured in this overview on the potential of microfluidics in The Scientist magazine.
BioE startup Aluna, founded by alumna Charvi Shetty, has been named a 2023-24 Tech for Global Good Laureate, one of four venures recognized for using technology to significantly advance health equity and improve lives. Aluna makes hardware and software that helps people with breathing problems.
Lucira, a Berkeley spinout company founded by BioE alumni Debkishore Mitra and John Waldeisen, has created the first combination home test for flu and COVID to be cleared by the FDA. The agency granted emergency use authorization to the Lucira Covid-19 & Flu Test, which provides results in about 30 minutes from samples collected by a nasal swab.
Aluna, an award-winning lung health management platform created by BioE alumna Charvi Shetty, has completed a $15.3 million Series B round of financing to continue growing its solution among doctors and patients managing asthma, cystic fibrosis and COPD. Aluna spun out of our undergraduate capstone course, BioE 192!
MEng alumna Alison Burklund, the cofounder and CTO of Nanopath, has been named to the Forbes 30 Under 30 list. Nanopath creates diagnostics that test pelvic and gynecologic infections during a single visit, so treatment can begin right away.
Check out this Medgadget interview with BioE alumna Charvi Shetty, founder and CEO of Aluna, which makes an FDA-approved at-home spirometer for asthma management.
Patrick Hsu’s lab has developed an RNA-extraction-free test for rapid viral detection using saliva via a microfluidic device. The fast, accurate, and portable prototype shows potential as a point-of-care system to support frequent, on-site molecular diagnostics. This work was the August 2022 cover story for Nature Biomedical Engineering.